Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 121 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 07/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 03/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 03/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/30/22
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 02/01/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 08/30/23
End: 08/01/29
Due: 08/01/30
Phase: N/A
Priority: Normal
Start: 01/03/25
End: 01/15/26
Due: 01/15/27
Phase: N/A
Priority: Normal
Start: 11/23/23
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 05/05/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 05/07/25
End: 12/31/26
Due: 12/31/27
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 01/01/11
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 12/01/16
Due: 12/01/17
Phase: N/A
Priority: Normal
Start: 01/01/14
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 02/11/23
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 05/30/25
End: 05/30/28
Due: 05/30/29
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 06/15/23
Due: 06/15/24
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 04/30/19
Due: 04/30/20
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 05/25/28
End: 05/26/31
Due: 05/26/32